Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

You raise not only an interesting point, but a recent story in the WSJ. Here it is, for your reading pleasure...

http://www.wsj.com/articles/drug-making-breaks-away-from-its-old-ways-1423444049?KEYWORDS=drug+making+breaks+away+from+its+old+ways

Very informative and one can extrapolate the meaning to Elite. A product that is easier to manufacture and qualifies as a generic would reduce costs for Elite and for the consumer. Greater likelihood it will be covered by healthcare as a generic and with better manufacturing there are reduced risks. What we sometimes miss are the force multipliers for Elite's tech and meds. And, it is worth reminding people that one of their little generics, Isradipine, has potential benefits for Parkinson's. While the drug will be going through FDA P-3 tests promulgated by the Michael J. Fox foundation through the NIH, its potential benefit will be part of any negotiated buyout. Can you imagine the value when (not if) that is added to a filed and approved ADT?